The Valley Desk

Clinical trial reporteLifePublished

Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional study

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
eLife
Published
Subject terms
Humans; Lipids; PPAR alpha; Treatment Outcome; Prospective Studies; Fenofibrate; COVID-19; SARS-CoV-2; Viruses; Cell biology; Medicine; Metabolic regulation
PubMed ID
36705566
PubMed Central ID
PMC9937660
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal